Dear Reader,


Welcome to the final issue of Drugs in R&D for 2023.

I would like to reflect on this year’s achievements and to thank all those who have contributed their valuable time and effort to the journal over the past 12 months.

I would like to start by thanking the authors of the articles published in Drugs in R&D over the course of 2023. The skill and dedication of these experts is critical to the continued success of the journal.

The high quality of articles published in the journal has been reflected in the most recent Impact Factor of 3.0 and CiteScore of 5.2.

I gratefully acknowledge all of the members of the journal’s Honorary Editorial Board, who have acted as peer reviewers and authors, and have provided guidance on journal content, policy and processes:


G. An, University of Iowa, Iowa, IA, USA

S. Ballet, Vrije Universiteit Brussel, Brussels, Belgium

S. Bellino, Centro Nazionale per la Ricerca, Rome, Italy

D. Cattaneo, Luigi Sacco University Hospital, Milan, Italy

S. Cheli, Luigi Sacco University Hospital, Milan, Italy

G. Cherala, Eastern Virginia Medical School, Norfolk, VA, USA

P.G. Cojutti, University of Udine, Udine, Italy

D. Danielak, Poznan University of Medical Science, Poznan, Poland

R.P. Dash, Johns Hopkins School of Medicine, Baltimore, MD, USA

M.A. Diniz, Samuel Oschin Comprehensive Cancer Institute, Los Angeles, CA, USA

K. Dua, University of Technology Sydney, Sydney, NSW, Australia

H. Fukase, Clinical Research Hospital Tokyo, Tokyo, Japan

R. Giusti, Sant'Andrea Hospital of Rome, Rome, Italy

I. Grabnar, University of Ljubljana, Ljubljana, Slovenia

C. Guillén-Ponce, Hospital Universitario Ramón y Cajal, Madrid, Spain

Y.K. Gupta, All India Institute of Medical Sciences, New Delhi, India

H.P. Hartung, Heinrich-Heine University, Dusseldorf, Germany

C. Höcht, University of Buenos Aires, Buenos Aires, Argentina

F. Jamali, University of Alberta, Edmonton, AB, Canada

G.A. Keller, University of Buenos Aires, Buenos Aires, Argentina

T.K.L. Kiang, The University of British Columbia, Vancouver, BC, Canada

M.J. McKeage, University of Auckland, Auckland, New Zealand

S. Mercadante, La Maddalena Cancer Center, Palermo, Italy

S. Misaka, Fukushima Medical University, Fukushima, Japan

P.J. Nathan, Monash University, Melbourne, VIC, Australia

J. Niu, FDA*, Silver Spring, MD, USA

F.J. Otero-Espinar, University of Santiago de Compostela, Santiago de Compostela, Spain

B.M. Patel, Nirma University, Ahmedabad, India

S. Perez-Lloret, Institute for Cardiology Research, National Research Council (ININCA-UBA-CONICET), Buenos Aires, Argentina

M. Pfister, University of Basel, Basel, Switzerland

V.P. Ranta, University of Eastern Finland, Kuopio, Finland

G. Remington, University of Toronto, Toronto, ON, Canada

Y. Saisho, Keio University School of Medicine, Tokyo, Japan

G.M.L. Santos, Brazilian Health Regulatory Agency, Brasilia, Brazil

H. Schütz, BEBAC Consulting, Vienna, Austria

D.R. Serrano, Complutense University of Madrid, Madrid, Spain

M.H. Shishehbor, Cleveland Clinic Cardiovascular Disease, Cleveland, OH, USA

L.P. Shulman, Feinberg School of Medicine of Northwestern University, Chicago, IL, USA

G. Singhania, CHI St. Vincent Infirmary, Little Rock, AK, USA

O. Slanař, Charles University, Prague, Czech Republic

A.G. Solano, Federal University of São João del-Rei, São João del-Rei, Brazil

L. Tóthfalusi, Semmelweis University, Budapest, Hungary

T. Van Duong, Purdue University, West Lafayette, IN, USA

M. Vissers, Centre for Human Drug Research, Leiden, The Netherlands

K. Vučićević, University of Belgrade, Belgrade, Serbia

J. Weiss, University of Heidelberg, Heidelberg, Germany

S. Yamada, Diabetes Center, Kitasato Institute Hospital, Tokyo, Japan

The quality of published articles is also testament to the significant efforts of the peer reviewers, whose commitment ensures that the journal’s content is held to the highest possible standard. We would therefore like to thank the following individuals who acted as reviewers for Drugs in R&D in the last 12 months:


Gianmarco Abbadessa, Italy

Claudia Altamura, Italy

Benny Amore, USA

Andreas Argyriou, Greece

Alain Astier, France

Ruggero Bacchin, Italy

Sagar S. Bachhav, USA

Maria A. Barbieri, Italy

Semih Başcı, Turkey

Cecilia Bender, Germany

Alexander Broomfield, UK

Andrea Buchacher, Austria

Adam Buckley, United Arab Emirates

Cherie Butts, USA

John G. Coghlan, UK

Paola Dell'Albani, Italy

Yomna Elleithi, Egypt

Michael Etscheid, Germany

Udoamaka Ezuruike, UK

Trine Frederiksen, Denmark

Anders Fuglsang, Denmark

Janice Garcia-Quiroz, Mexico

Nicola Gelbmann, Austria

Mohammed Ghazwani, Saudi Arabia

Parag Goyal, USA

Henry G. Grabowski, USA

Karin Hedenmalm, the Netherlands

Vincent Ho, Australia

Debasish Hota, India

Jie Huang, China

Slobodan M. Jankovic, Serbia

Anselm Jorda, Austria

Shohei Kikuchi, Japan

Csongor Kiss, Hungary

Daan Kremer, the Netherlands

Daan Lanser, the Netherlands

Anders Larsson, Sweden

Huiping Li, China

Li Liu, China

Xiao-Dong Liu, China

Ibrahim Mahmoud, USA

Daniel C. Malone, USA

Catia Marzolini, Switzerland

Luca Mastorino, Italy

Matteo Megna, Italy

Karolina Mėlinytė-Ankudavičė, Lithuania

Aleksander Mendyk, Poland

Brittany Merrill, USA

Milijana N. Miljković, Serbia

Toshihide Mimura, Japan

Barney Mitton, South Africa

Donald Moore, USA

Ryan Morgan, USA

Joanna J. Moser, Canada

Agata Mulak, Poland

Renato R.P. Munhoz, Canada

Natalia Navas, Spain

Jessica Nunes, USA

Hironao Okubo, Japan

Alexis Oliva, Spain

Federico Olivieri, Italy

Joshua Osowicki, Australia

Vasiliki Pantazou, France

Sathishbabu Paranthaman, India

Raquel Perez-Robles, Spain

Laure Peyro-Saint-Paul, France

JoAnn V. Pinkerton, USA

Donald Poirier, Canada

Efstathia Polychronopoulou, USA

Andrea Pozzi, Italy

Diane Ramsden, USA

Richard Riker, USA

Gaël Roué, Spain

Piero Ruscitti, Italy

Wojciech Rzechorzek, USA

Farshid Sadeghipour, Switzerland

Muhammad N.A. Sahid, Indonesia

Joshua H. Santos, Philippines

Vladimir Savransky, USA

Laila Selim, Egypt

Swapnil Sharma, India

Gauri Shishodia, USA

Stephen Shrewsbury, USA

Cristiana Sieiro Santos, Spain

Ravi S.P. Singh, USA

Karin Sipido, Belgium

Jakob Skov, Sweden

Frank Z. Stanczyk, USA

Isharyah Sunarno, Indonesia

Shindu Thomas, USA

Daniel J. Touw, the Netherlands

Jan-Alexis Tremblay, Canada

Karen Vertessen, the Netherlands

Karthick Vishwanathan, UK

Oliver von Richter, Germany

Chuang-Wei Wang, Taiwan, Republic of China

Thomas Wendl, Germany

Elena R. Wolff-Holz, Germany

Hongju Wu, USA

Ikuo Yamamiya, Japan

Gülbeyaz Yildiz Türkyilmaz, Turkey

Takashi Yoshikado, Japan

I hope that you have found the articles published throughout 2023 to be both interesting and informative. I have appreciated the high quality of content contributed to the journal and we look forward to keeping you up to date with topical issues in 2024.


With best wishes from the Editor of Drugs in R&D.

Anton van Rensburg